Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women
Clinical trial NCT05245734 · UNKNOWN
Trial details
- NCT number
- NCT05245734
- Sponsor
- Biopharma Plasma LLC
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2025-02-01
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.